Cassie Jung, Chief Operating Officer of Aquestive Therapeutics, Inc. (NASDAQ:AQST), filed a Form 4 on September 8, 2026, disclosing the exercise of a Common Stock Purchase Warrant on September 3, 2026.
James S. Mahan III, Chief Executive Officer and Director of Live Oak Bancshares, Inc., filed a Form 4 on September 8, 2026, disclosing the sale of 10,000 shares of Voting Common Stock on September 3, 2026, pursuant to a Rule 10b5-1 trading plan.
Hershey Trust Co, acting as trustee for Milton Hershey School, filed a Form 4 with the SEC on September 8, 2026, disclosing the sale of 18,000 shares of Hershey Co common stock across seven transactions on September 3 and September 4, 2026, pursuant to …
Director Tonya Williams Bradford filed a Form 4 with the SEC on September 8, 2026, reporting the sale of 1,600 shares of Live Oak Bancshares, Inc. voting common stock on September 3, 2026.
Zulfikar Jeevanjee, Executive Vice President and Chief Technology Officer of AIC at The Allstate Corporation, filed a Statement of Changes in Beneficial Ownership on September 8, 2026, reporting two transactions in Allstate common stock dated September 6, 2026.
Director William L. Williams III filed a Form 4 with the SEC on September 8, 2026, reporting the sale of 6,590 shares of Live Oak Bancshares, Inc. voting common stock on September 3, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.
Robert E. Gagnon, Chief Financial Officer of Opus Genetics, Inc. (NASDAQ:IRD), filed a Form 4 on September 8, 2026, disclosing the sale of 28,000 shares of common stock on September 3, 2026.
Director Cam Gallagher filed a Form 4 with the SEC on September 8, 2026, reporting the exercise of a warrant to acquire 784,314 shares of Opus Genetics, Inc. common stock at $1.15 per share, along with entry into a 180-day lock-up agreement with the …
Director Margaret M. Keane filed a Form 4 with the SEC on September 8, 2026, reporting a disposition of 944 shares of Allstate Corp common stock on September 3, 2026.
A statement of changes in beneficial ownership filed on September 8, 2026, disclosed that Lisa M. Campbell, a director of Dynatrace, Inc., acquired 506 shares of common stock through the vesting of restricted stock units on September 4, 2026.